<DOC>
	<DOCNO>NCT02475421</DOCNO>
	<brief_summary>The study aim evaluate elimination degradation glucagon patient type 2 diabetes compare match healthy subject .</brief_summary>
	<brief_title>Hyperglucagonaemia Patients With Type 2 Diabetes - Role Glucagon Clearance</brief_title>
	<detailed_description>In present project wish identify whether elimination degradation glucagon differ healthy control subject patient type 2 diabetes . Furthermore , wish examine whether obesity independent factor alter glucagon metabolism . Thus , examine glucagon elimination obese subject without type 2 diabetes lean subject without type 2 diabetes able describe metabolic clearance rate ( MCR ) glucagon broad spectrum individual different level insulin resistance beta cell dysfunction .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Patients type 2 diabetes Caucasians 35 year age diet or/and metformintreated type 2 diabetes least 3 month duration ( diagnose accord World Health Organization ( WHO ) criteria BMI either 27 33 kg/m^2 Normal haemoglobin Informed consent Subjects NGT Caucasians 35 year age BMI either 27 33 kg/m^2 Normal HbA1c ( accord WHO criterion ) Normal haemoglobin Informed consent Patients type 2 diabetes Inflammatory bowel disease Operation within last 3 month Severe kidney disease ( eGFR &lt; 60 ml/min ) Severe liver disease ( serum alanine aminotransferase ( ALAT ) and/or serum aspartate aminotransferase ( ASAT ) &gt; 2×normal value ) Pregnancy and/or breastfeed Age 80 year Any condition investigator feel would interfere trial participation Subjects NGT Diabetes Prediabetes ( impaired FPG HbA1c 42 mmol/mol ) Firstdegree relatives diabetes Inflammatory bowel disease Intestinal resection Severe kidney disease ( eGFR &lt; 60 ml/min ) Liver disease ( ALA T and/or serum ASA T &gt; 2×normal value ) Pregnancy and/or breastfeed Age 80 year Any condition investigator feel would interfere trial participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Glucagon</keyword>
	<keyword>Metabolic clearance rate glucagon</keyword>
</DOC>